Researchers analyzed EHR data on 28,118 patients who tested positive for COVID-19 in 2020 and 70,293 who tested negative. Researchers matched COVID-19-positive patients to negative patients by age, sex, testing month and service area, controlling for any preexisting conditions reported in the last four years. This comparison allowed researchers to identify when COVID-19 likely did not play a role in the development of a given symptom.
The 17 most frequent conditions associated with long COVID-19 were:
- Other lower respiratory disease
- Diabetes
- Gastrointestinal disease
- Conditions associated with dizziness or vertigo
- Abdominal pain
- Nonspecific chest pain
- Mental health
- Anxiety disorders
- Genitourinary symptoms and ill-defined conditions
- Malaise and fatigue
- Cardiac dysrhythmias
- Other nervous system disorders
- Respiratory failure, insufficiency, arrest
- Nausea and vomiting
- Fluid and electrolyte disorders
- Other nutritional, endocrine and metabolic disorders
- Anosmia
“The overall cumulative incidence of [ post-acute sequelae of SARS-CoV-2], as defined by COVID positive patients with a PASC-related diagnosis in the acute and persistent or late periods, is 16.5 percent,” study authors said. “These findings contribute to the overall evaluation of PASC and can be employed by clinicians in their care of patients who are diagnosed with COVID-19.”
View the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
